Literature DB >> 19672897

Clinical aspects of inflammatory bowel disease.

Britta Siegmund1, Martin Zeitz.   

Abstract

Inflammatory bowel disease (IBD) accompanies its patients throughout life. Current treatment options do not lead to a cure and are accompanied by significant toxicities. Numerous animal models contributed to the understanding of the pathogenesis of the disease and led to the development of novel treatment strategies. Genome-wide association analysis added a novel dimension. Here, we discuss how characterization of mutated genes in animal models supports the identification of future therapeutic targets.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19672897     DOI: 10.1002/eji.200939601

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  6 in total

1.  A retrospective, case-control study on traditional environmental risk factors in inflammatory bowel disease in Vukovar-Srijem County, north-eastern Croatia, 2010.

Authors:  Aleksandar Vcev; Davorin Pezerovic; Zeljko Jovanovic; Darko Nakic; Ivan Vcev; Ljiljana Majnarić
Journal:  Wien Klin Wochenschr       Date:  2015-03-28       Impact factor: 1.704

2.  Targeting improves MSC treatment of inflammatory bowel disease.

Authors:  In Kap Ko; Byung-Gyu Kim; Amad Awadallah; Jenifer Mikulan; Paul Lin; John J Letterio; James E Dennis
Journal:  Mol Ther       Date:  2010-04-13       Impact factor: 11.454

3.  Induction and activation of adaptive immune populations during acute and chronic phases of a murine model of experimental colitis.

Authors:  Lindsay J Hall; Emilie Faivre; Aoife Quinlan; Fergus Shanahan; Kenneth Nally; Silvia Melgar
Journal:  Dig Dis Sci       Date:  2010-05-14       Impact factor: 3.199

4.  Selenocoxib-3, a novel anti-inflammatory therapeutic effectively resolves colitis.

Authors:  Ramanpreet Kaur; Dhimant Desai; Shantu Amin; Kaisar Raza; Aman Bhalla; Pooja Yadav; Naveen Kaushal
Journal:  Mol Cell Biochem       Date:  2022-08-24       Impact factor: 3.842

5.  Histone deacetylase inhibitors modulate interleukin 6-dependent CD4+ T cell polarization in vitro and in vivo.

Authors:  Rainer Glauben; Elena Sonnenberg; Martin Wetzel; Paolo Mascagni; Britta Siegmund
Journal:  J Biol Chem       Date:  2014-01-13       Impact factor: 5.157

Review 6.  Anti-Adhesion Therapies in Inflammatory Bowel Disease-Molecular and Clinical Aspects.

Authors:  Sebastian Zundler; Emily Becker; Carl Weidinger; Britta Siegmund
Journal:  Front Immunol       Date:  2017-07-28       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.